Skip to search formSkip to main contentSkip to account menu

Taribavirin Hydrochloride

Known as: Viramidine Hydrochloride, Ribamidine Hydrochloride, 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamidine Hydrochloride 
A hydrochloride salt form of taribavirin, an orally available prodrug of ribavirin, a synthetic nucleoside analog of ribofuranose with activity… 
National Institutes of Health

Related topics

Related topics

2 relations

Narrower (1)

AVS 206
ribavirin amidine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Volume fractions of DCE-MRI parameter as early predictor of histologic response in soft tissue sarcoma: A feasibility study.
2013
2013
A Collaborative Neighbor Representation Based Face Recognition Algorithm
We propose a new collaborative neighbor representation algorithm for face recognition based on a revised regularized… 
Review
2008
Review
2008
Taribavirin for the treatment of chronic hepatitis C
Background: The current standard therapy for chronic hepatitis C virus (HCV), combination therapy with pegylated interferon and… 
Review
2007
Review
2007
Emerging strategies for pegylated interferon combination therapy
  • E. Schiff
  • Nature Clinical Practice Gastroenterology…
  • 2007
  • Corpus ID: 24025180
Several advances afford promise for improving the management of hepatitis C virus (HCV) infection. Current therapies primarily… 
2007
2007
Gateways to clinical trials.
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2006
2006
Influence of neoadjuvant chemotherapy on proliferation, apoptosis and multi-drug resistance in osteosarcoma cells
Objective: To study the influence of neoadjuvant chemotherapy on the expression of cyclin D1, Bcl-2, PCNA and Pgp in osteosarcoma… 
2004
2004
Viramidine hydrochloride: IMPDH inhibitor. Anti-hepatitis C virus drug
Hepatitis C virus (HCV) is a major cause of both acute and chronic hepatitis. It affects around 3% of the global population, and… 
2004
2004
Gateways to clinical trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
1988
1988
Synthesis and evaluation of 5-amino-1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine and certain related nucleosides as inhibitors of purine nucleoside phosphorylase.
The 5-amino and certain related derivatives of the powerful purine nucleoside phosphorylase (PNPase) inhibitor 1-beta-D… 
1980
1980
An in vivo and in vitro evaluation of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine: an inhibitor of human lymphoblast purine nucleoside phosphorylase.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)